Poolbeg Pharma Share Price | |
---|---|
Price | 13.45 |
Bid | 0.00 |
Ask | 0.00 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 13.45 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 500.00m |
Market Capitalisation | £67.25m |
Market Size | 30,000 |
52 Week High | 15.70 |
52 Week High Date | 07-May-2024 |
52 Week Low | 6.38 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | -17.02532 |
Earnings | -0.79 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
05-Jun-24 | 16:28:50 | 13.3975 | 29,927 | Sell* | 13.30 | 13.60 | 4,009 | O Ordinary |
05-Jun-24 | 15:44:13 | 13.54 | 39,631 | Buy* | 13.20 | 13.60 | 5,366 | O Ordinary |
05-Jun-24 | 15:18:09 | 13.60 | 100 | Buy* | 13.20 | 13.60 | 13.60 | O Ordinary Trade was executed as an SI |
05-Jun-24 | 15:18:09 | 13.60 | 7 | Buy* | 13.20 | 13.60 | 0.95 | O Ordinary Trade was executed as an SI |
05-Jun-24 | 15:18:09 | 13.60 | 100 | Buy* | 13.20 | 13.60 | 13.60 | O Ordinary Trade was executed as an SI |
05-Jun-24 | 15:12:03 | 13.47 | 50,000 | Buy* | 13.20 | 13.60 | 6,735 | O Ordinary |
05-Jun-24 | 14:29:32 | 13.244 | 60,405 | Sell* | 13.20 | 13.60 | 8,000 | O Ordinary |
05-Jun-24 | 14:27:08 | 13.225 | 37,808 | Sell* | 13.20 | 13.60 | 5,000 | O Ordinary |
05-Jun-24 | 14:26:29 | 13.50 | 22,918 | Buy* | 13.10 | 13.60 | 3,094 | O Ordinary |
05-Jun-24 | 14:20:02 | 13.20 | 52 | Sell* | 13.20 | 13.70 | 6.86 | O Ordinary Trade was executed as an SI |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
22-Feb-24 | 21-Feb-24 | Buy | Jeremy Skillington held the position of CEO at the time of this trade.Jeremy Skillington | 10.80 | GBX | 154,764 | 1,028,261 |
19-Feb-24 | 19-Feb-24 | Buy | Cathal Friel held the position of Executive Chairman at the time of this trade.Cathal Friel | 11.68 | GBX | 830,000 | 37,219,757 |
06-Oct-22 | 05-Oct-22 | Buy | Jeremy Skillington held the position of CEO at the time of this trade.Jeremy Skillington | 4.78 | GBX | 718,733 | 718,733 |
19-Jul-21 | 19-Jul-21 | Notification of Holding | Patrick J Ashe held the position of Independent Non-Executive Director at the time of this trade.Patrick J Ashe | 0.00 | 0 | 263,147 | |
19-Jul-21 | 19-Jul-21 | Notification of Holding | Cathal Friel held the position of Non-Executive Chairman at the time of this trade.Cathal Friel | 0.00 | 0 | 36,389,757 |
Welcome to Poolbeg Pharma plc which is listed on AIM (AIM:POLB). Keep up to date with our performance & latest news